Century Therapeutics, Inc. Gain (Loss) on Termination of Lease
Century Therapeutics, Inc. (IPSC) reported Gain (Loss) on Termination of Lease of -$11.14 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-08-12
- Century Therapeutics, Inc. gain (loss) on termination of lease for the quarter ending 2026-06-30 was -$11.14M.
- Century Therapeutics, Inc. gain (loss) on termination of lease for the quarter ending 2025-09-30 was $1.40M.
- Century Therapeutics, Inc. gain (loss) on termination of lease for fiscal 2025 was $1.40M.
- Century Therapeutics, Inc. gain (loss) on termination of lease for fiscal 2024 was -$959.00K.
| Period end | Gain (Loss) on Termination of Lease 1 month | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $11.00K 10-Q · filed 2026-08-12 | -$11.14M 10-Q · filed 2026-08-12 | -$11.14M 10-Q · filed 2026-08-12 | ||
| 2025-12-31 | $1.40M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $1.40M 10-Q · filed 2026-08-12 | $1.40M 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | -$959.00K 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$959.00K 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |